Genomic Health Reports 11 Percent Revenue Jump in Second Quarter | GenomeWeb

This article has been corrected to note that Brad Cole is Genomic Health's CFO and COO.

NEW YORK (GenomeWeb) – Genomic Health reported after the close of the market Tuesday that its second quarter revenues were up 11 percent year over year driven by increased sales for its Oncotype DX tests.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.